Simon Dai
Director
Simon serves as Chairman and CEO of Obagi China. Simon was previously the Chairman of Obagi Global Holdings. He led several investments in the healthcare space, including Obagi (acquired from Bausch Health) and Presbia (co-invested with Orchard Capital). Previously, Simon focused on impact investing at the Bill & Melinda Gates Foundation where he was a Liaison Officer based in Ethiopia. He also co-founded Oxford MEStar, a spin-out company from the Institute of Biomedical Engineering of Oxford University specializing in translational and regenerative medicine.